LSPLTirzepatide
Ordered Tirzepatide from LSPL? Mail in a sample (US only) and let us test it for free.
Test my supplyLSPL's tirzepatide record is held down by repeated purity misses, including 98.45% in January and 99.32%/99.3% in February-March. The latest results are cleaner, but batch detail gaps and fill swings keep the evidence mixed.
LSPL’s Facebook-only front end traces through ZZQ’s admin email to a Chinese IT registrant, while clone-like peptide storefronts sit on a shared IP/CMS stack. The report also documents a forum ban for incentivized reviews and COA provenance disputes.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including LSPL rows.
Cancel anytime
Ordered Tirzepatide from LSPL? Mail in a sample (US only) and let us test it for free.
Test my supplyAbout LSPL test results from Finnrick
LSPL is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 51 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible LSPL peptides in this dataset are GHK-Cu (6 tests), Retatrutide (24 tests) and Tirzepatide (21 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 51 recent tests.
Ordered Tirzepatide from LSPL? Mail in a sample (US only) and let us test it for free.
Test my supply